[1] |
WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua.
Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
|
[2] |
ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin.
Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
|
[3] |
SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing.
Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
|
[4] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[5] |
LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji.
Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
|
[6] |
WANG Yinghe, LI Mingqi, ZHAO Xiaolu, MA Yuehong.
Different Functions of Autophagy in Diseased Livers
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 956-960.
|
[7] |
QI Yujie, WANG Xin, ZHANG Jiahui, MA Enlong, GENG Xingchao.
Research Progress in Integration Sites for Cellular and Gene Therapy Products
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 721-727.
|
[8] |
LI Qiurong, FU Miaoqing, ZHOU Baishui, LI Cui, XIAO Xiaotong, YU Yuping, DENG Lu.
Mining of Real-World ADR Signals Related to Cefradine for Injection in 268 Cases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 790-793.
|
[9] |
LI Ying, HUANG Lishuang, ZHANG Jingjing, ZHU Yuanchao, SHEN Ji, YANG Jun.
Pharmaceutical Care to a Geriatric Syndrome Patient with Heart Failure Combined with Uremia
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 805-808.
|
[10] |
LIN Lu, ZHAO Anzhi, CHEN Jinhui, LI Zhongwen, HUANG Guohua, ZHONG Shilong.
One Case of Delayed Hypersensitivity Reactions Caused by Cefotaxime Sodium and Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 809-811.
|
[11] |
GAO Caiyun, WANG Boyuan, GAO Xiaojie.
Research Progress in Correlations between SGLT2 Inhibitors and Malignant Tumors
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 836-840.
|
[12] |
HU Haipeng, YAO Weijie, FENG Xin.
Effects of Yangxue Antai Prescription on Placental Ferroptosis in Recurrent Spontaneous Abortion Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 621-626.
|
[13] |
FU Rui, LUO Qian, PENG Bo, CHEN Weiya, WEI Xiaolu, CHEN Tengfei, SONG Ling, GAO Yunhang, ZHANG Guangping, HOU Hongping.
Efficacy of Tanreqing Aerosol Inhalation against Animals with Chronic Obstructive Pulmonary Disease and Mechanisms for Oxidative Stress and Mitochondrial Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 627-632.
|
[14] |
ZHENG Sili, ZHANG Xiaoqing.
133 Cases of Adverse Drug Reactions in Female Patients
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 654-658.
|
[15] |
LIANG Fanglin, CHEN Lingyuan, HU Danli, WEI Lingyun, WEI Tiemeng, ZHANG Faen, WEI Yana.
Immune-Related Adverse Events of Tislelizumab in 120 Patients with Hepatocellular Carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 659-663.
|